Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/110,510external-prioritypatent/US4364937A/en
Application filed by Ortho Pharma CorpfiledCriticalOrtho Pharma Corp
Publication of FI850484A0publicationCriticalpatent/FI850484A0/en
Publication of FI850484LpublicationCriticalpatent/FI850484L/en
Application grantedgrantedCritical
Publication of FI75435BpublicationCriticalpatent/FI75435B/en
Publication of FI75435CpublicationCriticalpatent/FI75435C/en
FI850484A1980-01-081985-02-06
DIAGNOSTIC FOERFARANDE, VID VILKET MAN UTNYTTJAR EN NY MONOCLONAL ANTIKROPP SPECIFIK MOT MAENNISKANS T-CELLERS ANTIGEN OCH I FOERFARANDET ANVAENDBAR COMPOSITION.
FI75435C
(en)
DIAGNOSTIC FOERFARANDE, VID VILKET MAN UTNYTTJAR EN NY MONOCLONAL ANTIKROPP SPECIFIK MOT MAENNISKANS T-CELLERS ANTIGEN OCH I FOERFARANDET ANVAENDBAR COMPOSITION.